|
Mpi Indium Dtpa In 111Drug - Mpi Indium Dtpa In 111 The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INTRATHECAL
Active Ingredient(s) -
Indium In-111 Pentetate Disodium
Strength -
1mCi/ML
Applicant -
GE HEALTHCARE
New Drug Application (NDA) Number -
017707
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Feb 18, 1982
Reference Listed Drug (RLD) -
No
Type -
RX
Applicant Full Name -
Ge Healthcare
Mpi Indium Dtpa In 111
Mpi Indium Dtpa In 111 1mci/ml Injectable; Intrathecal
Decabid Eq 50mg Base Tablet, Extended Release; Oral Decabid Eq 75mg Base Tablet, Extended Release; Oral Crixivan Eq 100mg Base Capsule; Oral Crixivan Eq 200mg Base Capsule; Oral Crixivan Eq 333mg Base Capsule; Oral Crixivan Eq 400mg Base Capsule; Oral Indiclor 2mci/0.2ml Injectable; Injection Indium In 111 Chloride 5mci/0.5ml Injectable; Injection Indium In-111 Oxyquinoline 1mci/ml Injectable; Injection NewDrugInformation |